These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 30743080)

  • 1. Rituximab therapy for primary central nervous system vasculitis: A 6 patient experience and review of the literature.
    Salvarani C; Brown RD; Muratore F; Christianson TJH; Galli E; Pipitone N; Cassone G; Huston J; Giannini C; Warrington K; Hunder GG
    Autoimmun Rev; 2019 Apr; 18(4):399-405. PubMed ID: 30743080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rituximab Versus Cyclophosphamide for Central Nervous System Involvement of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Case Series.
    Krishna R; De Giacomi F; Kumar N; Kalina P; Specks U; Baqir M
    J Clin Rheumatol; 2021 Mar; 27(2):64-72. PubMed ID: 31567753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rituximab treatment for IgA vasculitis: A systematic review.
    Hernández-Rodríguez J; Carbonell C; Mirón-Canelo JA; Diez-Ruiz S; Marcos M; Chamorro AJ
    Autoimmun Rev; 2020 Apr; 19(4):102490. PubMed ID: 32062030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term remission, relapses and maintenance therapy in adult primary central nervous system vasculitis: A single-center 35-year experience.
    Salvarani C; Brown RD; Christianson TJH; Huston J; Giannini C; Hunder GG
    Autoimmun Rev; 2020 Apr; 19(4):102497. PubMed ID: 32062032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab for remission induction in elderly patients with ANCA-associated vasculitis.
    Timlin H; Lee SM; Manno RL; Seo P; Geetha D
    Semin Arthritis Rheum; 2015 Aug; 45(1):67-9. PubMed ID: 25796088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rituximab as Induction Therapy in Eosinophilic Granulomatosis with Polyangiitis Refractory to Conventional Immunosuppressive Treatment: A 36-Month Follow-Up Analysis.
    Thiel J; Troilo A; Salzer U; Schleyer T; Halmschlag K; Rizzi M; Frede N; Venhoff A; Voll RE; Venhoff N
    J Allergy Clin Immunol Pract; 2017; 5(6):1556-1563. PubMed ID: 28916432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brief Report: Rituximab for the Treatment of Adult-Onset IgA Vasculitis (Henoch-Schönlein).
    Maritati F; Fenoglio R; Pillebout E; Emmi G; Urban ML; Rocco R; Nicastro M; Incerti M; Goldoni M; Trivioli G; Silvestri E; Mohammad AJ; Jayne D; Eriksson P; Segelmark M; Novikov P; Harris H; Roccatello D; Vaglio A
    Arthritis Rheumatol; 2018 Jan; 70(1):109-114. PubMed ID: 28973844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rituximab for treatment of severe renal disease in ANCA associated vasculitis.
    Geetha D; Hruskova Z; Segelmark M; Hogan J; Morgan MD; Cavero T; Eriksson P; Seo P; Manno RL; Dale J; Harper L; Tesar V; Jayne DR
    J Nephrol; 2016 Apr; 29(2):195-201. PubMed ID: 25986390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab maintenance therapy for granulomatosis with polyangiitis and microscopic polyangiitis.
    Roubaud-Baudron C; Pagnoux C; Méaux-Ruault N; Grasland A; Zoulim A; LE Guen J; Prud'homme A; Bienvenu B; de Menthon M; Camps S; LE Guern V; Aouba A; Cohen P; Mouthon L; Guillevin L;
    J Rheumatol; 2012 Jan; 39(1):125-30. PubMed ID: 22089465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rituximab therapy for Takayasu arteritis: a seven patients experience and a review of the literature.
    Pazzola G; Muratore F; Pipitone N; Crescentini F; Cacoub P; Boiardi L; Spaggiari L; Comarmond C; Croci S; Saadoun D; Salvarani C
    Rheumatology (Oxford); 2018 Jul; 57(7):1151-1155. PubMed ID: 28977672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety of Rituximab in Korean Patients with Refractory Inflammatory Myopathies.
    Ahn GY; Suh CH; Kim YG; Park YB; Shim SC; Lee SH; Lee SS; Bae SC; Yoo DH
    J Korean Med Sci; 2020 Sep; 35(38):e335. PubMed ID: 32989931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycophenolate mofetil in primary central nervous system vasculitis.
    Salvarani C; Brown RD; Christianson TJ; Huston J; Giannini C; Miller DV; Muratore F; Hunder GG
    Semin Arthritis Rheum; 2015 Aug; 45(1):55-9. PubMed ID: 25800827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up of patients who received repeat-dose rituximab as maintenance therapy for ANCA-associated vasculitis.
    Alberici F; Smith RM; Jones RB; Roberts DM; Willcocks LC; Chaudhry A; Smith KG; Jayne DR
    Rheumatology (Oxford); 2015 Jul; 54(7):1153-60. PubMed ID: 25477054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary central nervous system vasculitis: comparison of patients with and without cerebral amyloid angiopathy.
    Salvarani C; Brown RD; Calamia KT; Christianson TJ; Huston J; Meschia JF; Giannini C; Miller DV; Hunder GG
    Rheumatology (Oxford); 2008 Nov; 47(11):1671-7. PubMed ID: 18753193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and safety of low dose Rituximab as remission-maintenance treatment for patients with refractory idiopathic inflammatory myopathies: results of a retrospective study from a monocentric cohort.
    Gamba A; Depascale R; Zanatta E; Ienna L; Cruciani C; Gatto M; Zen M; Doria A; Iaccarino L
    Clin Rheumatol; 2024 Oct; 43(10):3167-3174. PubMed ID: 39196499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab treatment for chronic steroid-dependent Henoch-Schonlein purpura: 8 cases and a review of the literature.
    Crayne CB; Eloseily E; Mannion ML; Azerf SP; Weiser P; Beukelman T; Stoll ML; Feig DI; Prescott Atkinson T; Cron RQ
    Pediatr Rheumatol Online J; 2018 Nov; 16(1):71. PubMed ID: 30428889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rituximab for anti-neutrophil cytoplasmic antibodies-associated vasculitis: experience of a single center and systematic review of non-randomized studies.
    Ayan G; Esatoglu SN; Hatemi G; Ugurlu S; Seyahi E; Melikoglu M; Fresko I; Ozdogan H; Yurdakul S; Hamuryudan V
    Rheumatol Int; 2018 Apr; 38(4):607-622. PubMed ID: 29322343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti CD20 (Rituximab) therapy in refractory pediatric rheumatic diseases.
    Reis J; Aguiar F; Brito I
    Acta Reumatol Port; 2016; 41(1):45-55. PubMed ID: 27115107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rituximab in children with steroid-dependent nephrotic syndrome: experience of a tertiary center and review of the literature.
    Van Horebeek I; Knops N; Van Dyck M; Levtchenko E; Mekahli D
    Acta Clin Belg; 2017 Jun; 72(3):147-155. PubMed ID: 27409338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An update of the Mayo Clinic cohort of patients with adult primary central nervous system vasculitis: description of 163 patients.
    Salvarani C; Brown RD; Christianson T; Miller DV; Giannini C; Huston J; Hunder GG
    Medicine (Baltimore); 2015 May; 94(21):e738. PubMed ID: 26020379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.